Production (Stage)
Adicet Bio, Inc.
ACET
$0.6936
-$0.0251-3.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -117.32M | -117.12M | -117.88M | -137.29M | -139.79M |
| Total Depreciation and Amortization | 6.50M | 6.47M | 6.53M | 6.59M | 6.50M |
| Total Amortization of Deferred Charges | 15.00K | 39.00K | 40.00K | 41.00K | 52.00K |
| Total Other Non-Cash Items | 20.12M | 23.76M | 26.22M | 44.69M | 43.69M |
| Change in Net Operating Assets | -4.24M | -5.53M | -6.67M | -5.02M | -2.92M |
| Cash from Operations | -94.93M | -92.38M | -91.76M | -91.00M | -92.47M |
| Capital Expenditure | -2.37M | -1.12M | -1.08M | -1.58M | -2.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -119.49M | -118.12M | -- | -- | -- |
| Cash from Investing | -121.86M | -119.24M | -1.08M | -1.58M | -2.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 96.52M | 207.63M | 111.47M | 111.47M | 111.49M |
| Repurchase of Common Stock | -96.28M | -96.32M | -96.40M | -281.00K | -281.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 237.00K | 111.31M | 15.07M | 111.19M | 111.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -216.55M | -100.31M | -77.78M | 18.61M | 15.95M |